Module 12 - The Aspect of Gene Therapy
Module 12 - The Aspect of Gene Therapy
Lesson objective:
At the end of this module, the students should be able to:
1. Describe gene therapy and its various forms
2. Explore the opportunities that may be opened by gene therapy in the future.
3. Examine a bioethical issue from the viewpoint of various stakeholders.
4. Learn about the risks and potential outcomes involved in actual gene therapy
trials.
Gene therapy has been existence for almost half of century and is already the
standard care in certain procedures such as bone marrow transplants. The past decade
has seen this new and innovative science reach heights and has been proven to be
effective in treating diseases such as stroke, autism, Parkinson's, diabetes, spinal cord
injury and host of other ailments, both common and rare.
In 2013, La Union Rep. Eufranio Eriguel has introduced House Bill No. 212,
which would put up a “bioethics advisory board” that would establish “ethical standards”
governing the practice of stem cell therapy. Its purpose is to make the country a haven
for open technological innovation for stem cell, and will promote investment and
generate jobs. Further on, the Philippines may become known as hub for medical
tourism, with the surging increase of foreigners to come in for stem cell therapy that
some hospital in the country may offer at a much cheaper cost but with highest quality.
Source: https://ghr.nlm.nih.gov/primer/therapy/procedures
1
A gene that is inserted directly into a cell usually does not function. Instead, a carrier
called a vector is genetically engineered to deliver the gene. Certain viruses are often
used as vectors because they can deliver the new gene by infecting the cell. The
viruses are modified so they can't cause disease when used in people. Some types of
virus, such as retroviruses, integrate their genetic material (including the new gene) into
a chromosome in the human cell. Other viruses, such as adenoviruses, introduce their
DNA into the nucleus of the cell, but the DNA is not integrated into a chromosome.
Although gene therapy is a promising treatment option for a number of diseases, the
technique remains risky and is still under study to make sure that it will be safe and
effective. Gene therapy is currently being tested only for diseases that have no other
cures.
Source: https://socratic.org/questions/meiosis-occurs-in-
reproductive-cells-while-mitosis-occurs-in-somatic
A. Somatic gene therapy: transfer of a section of DNA to any cell of the body
that doesn’t produce sperm or eggs. Effects of gene therapy will not be
passed onto the patient’s children.
2
who have certain diseases or defects. There are three sources of autologous adult stem
cells:
1. Bone marrow, harvested by aspiration, is used to treat patient undergoing
chemotherapy.
2. Blood, collected through leukapheresis - a process where blood is drawn from the
patient, passed through a machine that selects only the stem cells and returns all
other components of the blood back to the patient. Bone marrow transplant and
blood stem transplantation is used to treat leukemia and lymphoma
3. Adipose tissue, have a capacity of self-renewal is harvested by liposuction. It is used
for clinical trials for the treatment of diabetes mellitus, liver disease, corneal lesions,
articular and cutaneous lesions, among others
Source: https://ghr.nlm.nih.gov/primer/therapy/procedures
a. Bone marrow stem cell b. blood stem cell
3
heal itself. The process needs an army of basic scientists in molecular biology,
biochemistry and biochemical engineering because every patient is unique. Model in
clinical trials in drugs doesn't apply to stem cell therapy. Gathering information from
other people may give you the clue but it doesn't give you the full information for each
patient.